Saltar al contenido principal

Systemic Amyloidosis due to Monoclonal Immunoglobulins, An Issue of Hematology/Oncology Clinics of North America

  • 1 Edición, Volumen 34-6 - 27 de octubre de 2020
  • Última edición
  • Editor: Raymond L. Comenzo
  • Idioma: Inglés

This issue of Hematology/Oncology Clinics, Guest Edited by Dr. Raymond L. Comenzo, is devoted to Systemic Amyloidosis due to Monoclonal Immunoglobulins. This issue is one of six… Leer más

Descripción

This issue of Hematology/Oncology Clinics, Guest Edited by Dr. Raymond L. Comenzo, is devoted to Systemic Amyloidosis due to Monoclonal Immunoglobulins. This issue is one of six selected each year by our series Consulting Editors, George P. Canellos and Edward J. Benz. Topics discussed in this important issue include: The Spectrum of Monoclonal Immunoglobulin Diseases, Systemic Amyloidosis due to Clonal Plasma Cell Diseases, Systemic Amyloidosis due to Low-grade Lymphomas, The Process of Amyloid Formation due to Monoclonal Immunoglobulins, Cardiac Involvement, Renal Involvement, Liver and Gastrointestinal Involvement, Peripheral Nervous System Involvement, Options for Chemotherapy, Stem-cell Mobilization and Autologous Transplant, Monoclonal Antibody Therapies, Solid Organ Transplant, Supportive Care, Patient Voices, and Future Perspectives.

Detalles del producto

  • Edición: 1
  • Última edición
  • Volumen: 34-6
  • Publicado: 27 de octubre de 2020
  • Idioma: Inglés

Sobre el editor

RC

Raymond L. Comenzo

Afiliaciones y experiencia
By Raymond L. Comenzo, MD., Director, Transfusion Services Director, John C. Davis Myeloma and Amyloid Program Professor, Tufts University School of Medicine Tufts Medical Center and Tufts University School of Medicine Boston, MA, USA